On the other hand, we see an increase in risk-weighted assets up to the crisis, with a slight drop afterwards and the trend steadying since then. The deal will free up capital of some EUR 400 million, primarily by reducing risk-weighted assets by EUR 4.
The Heska Corporation is involved in biotechnical research for the development of vaccines and related diagnostic products for companion animals. The company manufactures health care products for dogs, cats, and horses and markets them to veterinarians.
IMPROVING THE WORLD IN WHICH WE LIVE. Kaneka Corporation of Osaka, Japan is a $5 billion* producer of chemical products including resins, pharmaceutical intermediaries, food supplements, synthetic fibers, and fine chemicals.